MedinCell SA (MEDCL) Stock Statistics & Valuation Metrics

MedinCell SA has a market cap or net worth of €573.93M. The enterprise value is €445.28M.

MedinCell SA has 33,083,675 shares outstanding. The number of shares has decreased by -2.65% in one year.

MedinCell SA’s return on equity (ROE) is 1.13 and return on invested capital (ROIC) is -16.11%.

The current PE Ratio of MedinCell SA is ―. MedinCell SA’s PEG ratio is ―.

In the last 12 months, MedinCell SA had revenue of 25.54M and earned -18.44M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was 21.40M and capital expenditures -367.00K, giving a free cash flow of 21.03M billion.

MedinCell SA pays an annual dividend of ―, resulting in a dividend yield of ―

MedinCell SA upcoming earnings date is Dec 9, 2025, During Market Hours (Confirmed).

MedinCell SA as a current ratio of 2.70, with Debt / Equity ratio of -128.07%

In the past 12 months, MedinCell SA has paid 160.00K in taxes.

MedinCell SA EV to EBITDA ratio is 0.03, with an EV/FCF ratio of -0.02.

MedinCell SA has €38.85M in cash and marketable securities with €69.19M in debt, giving a net cash position of €30.34M billion.

Gross margin is 100.00%, with operating margin of -42.44%, and net profit margin of -72.19%.

The average price target for MedinCell SA is €25.60, which is 11.43% higher than the current price. The consensus rating is Moderate Buy